In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ryan Nelson

Editor-in-Chief, Medtech Insight, HBW Insight

Washington, D.C.

Ryan Nelson has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for The Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of The Rose Sheet. In his current role, he oversees and heads up strategy for Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA.

Latest From Ryan Nelson

L’Oreal To Fuel Continued Dermocosmetics Growth With Skinbetter Science Acquisition

Phoenix, AZ-based Skinbetter Science “has become one of the fastest growing medical-dispensed skincare brands in the United States,” recording nearly $95m in sales for the 12-month period ended 31 August 2022, and shows “great international potential,” according to L’Oreal leadership.

M & A Business Strategies

Cosmetics Industry Still Committed To Reg Modernization, But FDA User-Fee Reauthorization May Not Be Vehicle

A “clean” FDA user-fee reauthorization bill – minus cosmetics modernization provisions – could be the likeliest way forward with user-fee program funding set to elapse at the end of September, a PCPC rep suggested in an email to HBW Insight.

Legislation Cosmetics

IBA President Don Frey On 'Inside The Box' Innovation And Sensible Cosmetics Legislation

The Honest Company alum brings to the Independent Beauty Association an extensive R&D background and the conviction that constraints on businesses today can and should foster innovation. That said, unduly burdensome legislation threatens to have a stifling effect on cosmetics innovation, the group’s new president and CEO tells HBW Insight in Part 2 of this interview.

Leadership Innovation

Microplastic Must Be Gone From Makeup, Lip, Nail Cosmetics In 12 Years – EU Commission

The Commission’s long-awaited draft regulation extends the phase-out period for microplastic in selected leave-on cosmetics from six to 12 years. That’s a win for industry, but tens of thousands of formulations still must be reformulated in a market where suitable alternative ingredients have been characterized as scarce to nonexistent.

Regulation Cosmetic Ingredients

Beiersdorf To Settle Benzene-In-Sunscreen Litigation For $2.3M

Benzene contamination of Coppertone sunscreen products will cost Beiersdorf $2.3m and require 18 months of benzene testing under a settlement reached with plaintiff Almany Ismael Bangoura, on behalf of himself and consumers nationwide, in New York federal court.

Legal Issues Quality

CEO Don Frey On Helming Independent Beauty Association In ‘Unprecedented’ Climate

Joining IBA from The Honest Company, where he headed up innovation, Frey aims to promote networking and collaboration within the group’s membership in an environment where in-person events – and travel budgets – still have not returned to pre-pandemic levels. Frey spoke with HBW Insight about his career to date and his goals for IBA in the near and longer terms.

StartUps and SMEs Supply Chain
See All
UsernamePublicRestriction

Register